Search Results - C. Oliver Hanemann

Refine Results
  1. 1
    Magic but treatable? Tumours due to loss of Merlin

    Magic but treatable? Tumours due to loss of Merlin by C. Oliver Hanemann

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Merlin, a multi‐suppressor from cell membrane to the nucleus

    Merlin, a multi‐suppressor from cell membrane to the nucleus by Lü Zhou, C. Oliver Hanemann

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Schwannomas and Their Pathogenesis

    Schwannomas and Their Pathogenesis by David A. Hilton, C. Oliver Hanemann

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The Tumor Suppressor Merlin Controls Growth in Its Open State, and Phosphorylation Converts It to a Less-Active More-Closed State

    The Tumor Suppressor Merlin Controls Growth in Its Open State, and Phosphorylation Converts It to a Less-Active More-Closed State by Ifat Sher, C. Oliver Hanemann, P. Andrew Karplus, Anthony Bretscher

    Published 2012
    Get full text
    Carta
    Save to List
    Saved in:
  5. 5
    Δ<sup>9</sup>‐tetrahydrocannabinol (Δ<sup>9</sup>‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

    Δ<sup>9</sup>‐tetrahydrocannabinol (Δ<sup>9</sup>‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease by Camille Carroll, Marie‐Louise Zeissler, C. Oliver Hanemann, John Zajicek

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Dissecting and Targeting the Growth Factor–Dependent and Growth Factor–Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma

    Dissecting and Targeting the Growth Factor–Dependent and Growth Factor–Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma by Sylwia Ammoun, Christine Flaiz, Natalia Ristic, Jennifer Schuldt, C. Oliver Hanemann

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2

    Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2 by Sylwia Ammoun, M. Caroline Schmid, J. Triner, Paul W. Manley, C. Oliver Hanemann

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways

    Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways by Lü Zhou, Emanuela Ercolano, Sylwia Ammoun, M. Caroline Schmid, Magdalena Barczyk, C. Oliver Hanemann

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2

    Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2 by A.D Sperfeld, Claudine Hein, J. M. Schröder, Albert C. Ludolph, C. Oliver Hanemann

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Accumulation of autophagosomes confers cytotoxicity

    Accumulation of autophagosomes confers cytotoxicity by Robert W. Button, Sheridan L. Roberts, Thea L. Willis, C. Oliver Hanemann, Shouqing Luo

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis

    Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis by Marie‐Louise Zeissler, Jordan Eastwood, Kieran McCorry, C. Oliver Hanemann, John Zajicek, Camille Carroll

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use

    Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use by Chetan Bettegowda, Meena Upadhayaya, D. Gareth Evans, AeRang Kim, Dimitrios Mathios, C. Oliver Hanemann

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Artesunate induces necrotic cell death in schwannoma cells

    Artesunate induces necrotic cell death in schwannoma cells by Robert W. Button, Fang Lin, Emanuela Ercolano, Joseph H. Vincent, Bing Hu, C. Oliver Hanemann, Shouqing Luo

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Tumour-associated macrophage infiltration differs in meningioma genotypes, and is important in tumour dynamics

    Tumour-associated macrophage infiltration differs in meningioma genotypes, and is important in tumour dynamics by Ting Zhang, Claire Adams, György Fejér, Emanuela Ercolano, Jonathan Cutajar, Juri Na, Felix Sahm, C. Oliver Hanemann

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival

    Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival by Sylwia Ammoun, Lucy Provenzano, Lü Zhou, Magdalena Barczyk, Kevin Gregory-Evans, David A. Hilton, Sassan Hafizi, C. Oliver Hanemann

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism

    Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism by Jemma Dunn, Sara Ferluga, Vikram Sharma, Matthias E. Futschik, David A. Hilton, Claire Adams, Edwin Lasonder, C. Oliver Hanemann

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Tetracycline-inducible transgene expression mediated by a single AAV vector

    Tetracycline-inducible transgene expression mediated by a single AAV vector by A. Chtarto, Hans‐Ulrich Bender, C. Oliver Hanemann, Tim J. Kemp, Enni Lehtonen, Marc Levivier, Jacques Brotchi, Thierry Velu, Liliane Tenenbaum

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma

    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma by Sylwia Ammoun, Clare H. Cunliffe, Jeffrey C. Allen, Luis Chiriboga, Filippo G. Giancotti, David Zagzag, C. Oliver Hanemann, Matthias A. Karajannis

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Achieving consensus for clinical trials

    Achieving consensus for clinical trials by Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus

    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus by Wei Li, Jonathan M. Cooper, Lü Zhou, Chenyi Yang, Hediye Erdjument‐Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C. Oliver Hanemann, Pengbo Zhou, Matthias A. Karajannis, Filippo G. Giancotti

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: